Synthesis and antimuscarinic activity of some ether- and thioether-bearing 1,3-dioxolanes and related sulfoxides and sulfones

Bioorganic and Medicinal Chemistry

Volumn 6, Issue 6, 1998, Pages 825-832

  Malmusi, Luca ^a   Franchini, Silvia ^a   Mucci, Adele ^a   Schenetti, Luisa ^a   Gulini, Ugo ^b   Marucci, Gabriella ^b   Brasili, Livio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ANTICHOLINERGIC EFFECT; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; MALE; NONHUMAN; RABBIT; RECEPTOR AFFINITY;

ANIMALS; DIOXOLANES; GUINEA PIGS; HEART; ILEUM; MALE; MUSCARINIC ANTAGONISTS; RABBITS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONES; SULFOXIDES; VAS DEFERENS;

EID: 0031805937     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(98)00042-X     Document Type: Article

References (27)

1. Bonner, T. I. Trends Neurosci. 1989, 6, 328.
2. Hulme, E. C.; Birdsall, N. J. M.; Buckley, N. J. Ann. Rev. Pharmacol. 1990, 30, 633.
3. Doods, H. N.; Mathy, M. J.; Davidesko, D.; Van Charldorp, K. J.; De Jonge, A.; Van Zwieten, P. A. J. Pharmacol. Exp. Ther. 1987, 242, 257.
4. Receptor & Ion Channel Nomenclature. Trends Pharmacol. Sci. (Suppl.), 1995.
5. Engel, W.; Doods, H.; Wetzel, B. Drugs Future, 1990, 15, 9.
6. Kramer, W.; Gonne, S. Int. J. Exp. Clin. Pharmacol. 1988, 37, 48.
7. Mutschler, E.; Feifel, R.; Moser, U.; Tacke, R.; Wess, J. Lambrecht, G. Eur. J. Pharmacol. 1990, 183, 117.
8. Jean, J. C.; Moos, W. H.; Johnson, G. Bioorg. Med. Chem. Lett. 1992, 2, 777.
9. Doods, N. H.; Quirion, R.; Mihm, G.; Engel, W.; Rudolf, K.; Enzeroth, M.; Schiavi, G. B.; Ladinsky, H.; Bechtel, W. O.; Ensinger, H. A.; Mendla, K. D.; Eberlein, W. Life Sci. 1993, 52, 497.
10. Barnes, P. J. Eur. Respir. J. 1993, 6, 328.
11. May, M.; Ridley, H. F.; Triggle, D. J. J. Med. Chem. 1969, 12, 320.
12. Brimblecombe, R. W.; Inch, T. D. J. Pharm. Pharmacol. 1970, 22, 881.
13. Chang, K. J.; Deth, R. C.; Triggle, D. J. J. Med. Chem. 1972, 15, 243.
14. Piergentili, A.; Quaglia, W.; Tayebati, S. K.; Paparelli, F.; Malmusi, L.; Brasili, L. Il Farmaco 1994, 49, 83.
15. Thurkauf, A.; Jacobson, A. E.; Rice, K. C. Synthesis 1988, 233.
16. Neuhaus, D.; Williamson, M. P. In The Nuclear Overhauser Effect in Structural and Conformational Analysis; VCH: New York, 1989.
17. Mucci, A.; Schenetti, L.; Brasili, L.; Malmusi, L. Magn. Reson. Chem. 1995, 33, 167.
18. Malmusi, L.; Mucci, A.; Schenetti, L.; Gulini, U.; Marucci, G.; Brasili, L. Bioorg. Med. Chem. 1996, 4, 2071.
19. Witanowsky, M.; Webb, G. A. In Nitrogen NMR; Witanowsky, M.; Webb, G. A., Eds.; Plenum: London, 1973; pp 1-39.
20. Lehn, J. M.; Kintzinger, J. P. In Nitrogen NMR; Witanowsky, M.; Webb, G. A, Eds.; Plenum: London, 1973; pp 79-161.
21. Axenrod, T. In Nitrogen NMR; Witanowsky, M.; Webb, G. A., Eds.; Plenum: London, 1973; pp 261-317.
22. Angeli, P.; Brasili, L.; Gulini, U.; Marucci, G.; Paparelli, F. Med. Chem. Res. 1992, 2, 74.
23. Doods, H. N.; Entzeroth, M.; Ziegler, H.; Mayer, N.; Holzer, P. Eur. J. Pharmacol. 1994, 255, 275.
24. Eltze, M. Eur. J. Pharmacol. 1988, 151, 275.
25. Van Rossum, J. M. Arch. Int. Pharmacodyn. Ther. 1963, 143, 299.
26. Arunlakshana, O.; Schild, H. O. Br. J. Pharmacol. 1959, 14, 48.
27. Tallarida, R. J.; Cowan, A.; Adler, M. W. Life Sci. 1979, 25, 637.